Matchpoint Therapeutics
Jennifer Alley has a diverse work experience spanning over 25 years in the pharmaceutical industry. Most recently, they have been working at Matchpoint Therapeutics as a Senior Principal Scientist since May 2021. Prior to that, they worked at Quench Bio as a Principal Scientist from June 2020 to April 2021.
Jennifer also had a long tenure at Pfizer, where they held the position of Principal Scientist from November 2009 to June 2020. Before joining Pfizer, they worked at Millennium Pharmaceuticals as a Research Investigator from January 2000 to November 2005. Jennifer also gained experience at LeukoSite as a Scientist from June 1999 to December 1999, and at Cubist Pharmaceuticals as a Research Associate from July 1996 to June 1999.
Based on their extensive work history, Jennifer has developed a strong expertise in scientific research and has held various senior roles throughout their career.
Jennifer Alley attended Worcester Polytechnic Institute from 1992 to 1996 and earned a Bachelor's degree. The field of study is not specified.
This person is not in any offices
Matchpoint Therapeutics
Matchpoint is a biotechnology company harnessing the power of covalency to discover precision covalent medicines to transform the treatment of immune diseases and other serious illnesses. The company's proprietary Advanced Covalent Exploration (ACE) platform integrates advanced chemoproteomics, machine learning, and covalent chemistry libraryevolution. Matchpoint has an emerging pipeline of novel covalent medicines, initially focused on immunology.